Related Experiment Video
Updated: Apr 23, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
[Acute atrio-ventricular block in sickle cell anemia]
P-H Gacon1, P Jourdain2, N Heba3
1Service de cardiologie clinique et interventionnelle, hôpital Bocage central, CHU de Dijon, 21079 Dijon cedex, France.
Sickle cell disease can cause temporary atrio ventricular block in Black patients. Promptly ruling out sickle cell disease is crucial for Black individuals presenting with AV block, as it can lead to conduction abnormalities.
Area of Science:
- Cardiology
- Hematology
Context:
- Sickle cell disease (SCD) disproportionately affects individuals of Black descent.
- Acute myocardial damage during SCD vaso-occlusive crises is reported, but atrio ventricular (AV) block risk is understudied.
Purpose:
- To investigate the occurrence and characteristics of acute atrio ventricular block in patients with sickle cell disease.
Summary:
- A survey of ten patients (mean age 39) with SCD experiencing acute AV block revealed transitory conduction abnormalities.
- Common symptoms included asthenia and shortness of breath; four had second-degree and six had third-degree AV block.
- Treatment involved conservative measures, and all AV blocks resolved without pacemaker implantation.
Impact:
- This study represents the largest survey on transitory AV block in SCD patients.
- Findings suggest localized ischemia in the AV node/His bundle area as the cause of conduction defects.
- Highlights the importance of considering SCD in Black patients presenting with AV block.
More Related Videos
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

